Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$10.61 USD
+0.09 (0.86%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $10.67 +0.06 (0.57%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-5.22 | 0.00% |
Earnings Summary
For their last quarter, Cidara Therapeutics (CDTX) reported earnings of -$2.05 per share, beating the Zacks Consensus Estimate of $-3.94 per share. This reflects a positive earnings surprise of 47.97%. Look out for CDTX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$5.22 per share, reflecting a year-over-year decrease of 190%.
Earnings History
Price & Consensus
Zacks News for CDTX
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
CDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services